Literature DB >> 11405274

Characterization of coagulase from Staphylococcus intermedius.

Y Komori1, N Iimura, R Yamashita, H Sugihara, T Nikai.   

Abstract

A protein coagulase was isolated from Staphylococcus intermedius 6131 using bovine prothrombin-Sepharose 4B and Bio-gel P-4 column chromatographies. Homogeneity was demonstrated by the formation of a single band in polyacrylamide gel electrophoresis and isoelectric focusing. The purified preparation possesses a molecular weight of 64,500, an isoelectric point of 4.1, consists of 615 total amino acid residues and demonstrates coagulase activity for human and rabbit fibrinogen, but does not show the activity for rat or guinea pig fibrinogens. This purified protein contains galactose and fucose, and the amino-terminal amino acid sequence was determined. The coagulase activity is inhibited by N-bromosuccinimide (NBS), suggesting that tryptophan is involved in this activity. The coagulase was heat stable to 80 degrees C and stable to pH over the range of 7-9. This is the first report of coagulase from Staphylococcus intermedius.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405274

Source DB:  PubMed          Journal:  J Nat Toxins        ISSN: 1058-8108


  3 in total

1.  Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus.

Authors:  S Watanabe; T Ito; F Takeuchi; M Endo; E Okuno; K Hiramatsu
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

2.  Identification, Cloning, and Characterization of Staphylococcus pseudintermedius Coagulase.

Authors:  Alaa H Sewid; M Nabil Hassan; A M Ammar; David A Bemis; Stephen A Kania
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

3.  Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus.

Authors:  Shinya Watanabe; Teruyo Ito; Takashi Sasaki; Shanshuang Li; Ikuo Uchiyama; Kozue Kishii; Ken Kikuchi; Robert Leo Skov; Keiichi Hiramatsu
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.